Cismaru Gabriel, Gusetu Gabriel, Muresan Lucian, Rosu Radu, Andronache Marius, Matuz Roxana, Puiu Mihai, Mester Petru, Miclaus Maria, Pop Dana, Mircea Petru Adrian, Zdrenghea Dumitru
Department of Cardiology, Rehabilitation Hospital, University of Medicine and Pharmacy "IuliuHatieganu," Cluj-Napoca, Romania.
CHU de Nancy, Department of Cardiology, University Hospital Nancy, France.
Pacing Clin Electrophysiol. 2015 Jul;38(7):857-63. doi: 10.1111/pace.12641. Epub 2015 May 6.
Ventriculo-atrial (VA) conduction can have negative consequences for patients with implanted pacemakers and defibrillators. There is concern whether impaired VA conduction could recover during stressful situations. Although the influence of isoproterenol and atropine are well established, the effect of adrenaline has not been studied systematically. The objective of this study was to determine if adrenaline can facilitate recovery of VA conduction in patients implanted with pacemakers.
A prospective study was conducted on 61 consecutive patients during a 4-month period (April-July 2014). The presence of VA conduction was assessed during the pacemaker implantation procedure. In case of an impaired VA conduction, adrenaline infusio was used as a stress surrogate to test conduction recovery.
The indications for pacemaker implantation were: sinus node dysfunction in 18 patients, atrioventricular (AV) block in 40 patients, binodal dysfunction (sinus node+ AV node) in two patients and other (carotid sinus syndrome) in one patient. In the basal state, 15/61 (24.6%) presented spontaneous VA conduction and 46/61 (75.4%) had no VA conduction. After administration of adrenaline, there was VA conduction recovery in 5/46 (10.9%) patients.
Adrenaline infusion produced recovery of VA conduction in 10.9% of patients with absent VA conduction in a basal state. Recovery of VA conduction during physiological or pathological stresses could be responsible for the pacemaker syndrome, PMT episodes, or certain implantable cardiac defibrillator detection issues.
心室-心房(VA)传导对植入起搏器和除颤器的患者可能产生不良后果。人们担心在应激情况下,受损的VA传导是否能够恢复。尽管异丙肾上腺素和阿托品的影响已得到充分证实,但肾上腺素的作用尚未进行系统研究。本研究的目的是确定肾上腺素是否能促进植入起搏器患者的VA传导恢复。
在2014年4月至7月的4个月期间,对61例连续患者进行了一项前瞻性研究。在起搏器植入过程中评估VA传导情况。如果VA传导受损,则使用肾上腺素输注作为应激替代手段来测试传导恢复情况。
起搏器植入的适应证为:18例患者为窦房结功能障碍,40例患者为房室(AV)阻滞,2例患者为双结功能障碍(窦房结+房室结),1例患者为其他情况(颈动脉窦综合征)。在基础状态下,15/61(24.6%)患者出现自发VA传导,46/61(75.4%)患者无VA传导。给予肾上腺素后,5/46(10.9%)患者的VA传导恢复。
在基础状态下无VA传导的患者中,10.9%在输注肾上腺素后VA传导恢复。生理或病理应激期间VA传导的恢复可能是起搏器综合征、起搏器介导的心动过速发作或某些植入式心脏除颤器检测问题的原因。